Huimin Wang - Edwards Lifesciences Insider

Edwards Lifesciences Corporation -- USA Stock  

USD 134.67  2.52  1.84%

Corporate Vice President Japan, Asia Pacific

Dr. Huimin Wang M.D., is Corporationrationrate Vice President, Japan, Asia Pacific of Edwards Lifesciences Corporationrationration. From 2004 to 2010. Dr. Wang was Corporationrationrate Vice President, Japan, Asia and Pacific since 2010. Previously, he served in a number of roles with Baxter Healthcare Corporationrationration, including Senior Manager of Strategy Development, Director of ProductTherapy for the Renal Division in Japan, President of Medical Systems and Devices in Japan, and was a representative director of Baxter Limited, a Japan corporation, through September 2002. Before joining Baxter, Dr. Wang was a senior associate with Booz, Allen Hamilton in Chicago, Vice President of Integrated Strategies, a consulting and venture management firm he cofounded, and an associate with McKinsey Company. Dr. Wang is a Visiting Associate Professor of anesthesiology at Keio University
Age: 59  President Since 2010  MBA    
949-250-2500  http://www.edwards.com
Wang earned his Doctor of Medicine degree from Kagoshima University in Japan and was a Resident and Staff Physician in anesthesiology at Keio University Hospital in Tokyo. He earned his MBA from the University of Chicago.

Huimin Wang Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 12.54 % which means that for every $100 of asset it generated profit of $12.54. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 20.94 % which means that it produced $20.94 on every 100 dollars invested by current stockholders.
The company reports 1.04 B of total liabilities with total debt to equity ratio (D/E) of 35.0 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 1.76 which is generally considered normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

Peyton HowellKorenAmerisourceBergen Corporation
2014
David QuellerExpress Scripts Holding Company
2014
Bradley PhillipsExpress Scripts Holding Company
2017
Jeffrey ShermanBecton Dickinson and Company
2006
Stephen SichakBecton Dickinson and Company
2009
Louise MehrotraJohnson Johnson
2013
Phyllis AndersonExpress Scripts Holding Company
2015
Jerome HurwitzBecton Dickinson and Company
2013
Alberto MasBecton Dickinson and Company
2016
Joseph WolkJohnson Johnson
2016
Britt VitaloneMcKesson Corporation
2018
Alexandre ConroyBecton Dickinson and Company
2012
Thomas PolenBecton Dickinson and Company
2017
Kathy GaddesAmerisourceBergen Corporation
2016
Patricia MorrisonCardinal Health
2011
Lawrence MarshAmerisourceBergen Corporation
2014
David NeuAmerisourceBergen Corporation
2015
Neal SampleExpress Scripts Holding Company
2018
Linda TharbyBecton Dickinson and Company
2016
Scott PleauBaxter International
2017
Christine HoustonExpress Scripts Holding Company
2018

Entity Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and traded on New York Stock Exchange. It employs 12200 people.Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 12,200 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Edwards Lifesciences Leadership Team

John Cardis, Director
Wesley Schack, Director, MBA
Larry Wood, VP, MBA
Nicholas Valeriani, Director, MBA
Leslie Heisz, Director, MBA
Catherine Szyman, President, MBA
Martha Marsh, Director, MBA
Huimin Wang, President, MBA
Barbara McNeil, Director, Ph.D
Steven Loranger, Director
William Link, Director
Scott Ullem, CFO, MBA
Patrick Verguet, VP, Ph.D
Kieran Gallahue, Director, MBA
Bernard Zovighian, President, MBA
David Erickson, President
Donald Bobo, VP
Michael Mussallem, Chairman, Ph.D

Stock Performance Indicators

Did you try this?

Run Focused Opportunities Now
   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
View All  Next Launch Focused Opportunities

BATS Exchange Efficient Frontier

Diversify in USA Market
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
Diversify Portfolios
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1) For any level of risk, select the one which has the highest expected return. 2) For any expected return, select the one which has the lowest volatility.
Diversify Portfolios
Additionally see Investing Opportunities. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.